| 1 |
34791831 | Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics. | 2022 Jan |
3 |
| 2 |
32558923 | Effect of High-Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long-lasting Inhibition of CYP2C19. | 2020 Dec |
2 |
| 3 |
28875498 | Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype. | 2018 May |
1 |
| 4 |
26661629 | Esomeprazole induced galactorrhea: a novel side effect. | 2016 Feb |
1 |
| 5 |
23857299 | In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors. | 2013 Oct |
1 |
| 6 |
16338278 | Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data. | 2005 Dec |
1 |
| 7 |
11475467 | Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole. | 2001 |
1 |